Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Emergency aid for overdoses

  • Improving bladder function among people with spinal cord injuries

  • Blinded by non-science: Trivial scientific information increases trust in products

  • Pathological gambling is associated with altered opioid system in the brain

  • Highly connected CEOs more likely to broker mergers and acquisitions that harm firms, study shows

  • Heart rate may predict survival, brain function in comatose cardiac arrest survivors

  • Cold sores increase risk of dementia, research suggests

  • User-friendly electronic 'Eyecane' enhances navigational abilities for blind

  • Design of micro, nanoparticles to improve treatments for Alzheimer's, Parkinson's

  • Sexual preference for masculine men, feminine women is an urban habit

  •